Table 1 Comparison of KSHV DNA and KSHV seropositivity among 155 HIV-positive incident NHL cases compared to 155 HIV-positive matched controls.
OR (95% CI) | |||
|---|---|---|---|
N | Univariate | Multivariate | |
KSHV serum DNA: ≥1 copy detected | 310 | 2.3 (1.1-5.1) | 1.5 (0.53-3.9) |
Among subset with serum within 1 year before diagnosis | 130 | 1.2 (0.37-3.9) | 0.81 (0.14-4.7) |
Among subset without Kaposi sarcoma diagnosis | 216 | 4.0 (1.13-14) | 1.9 (0.37-9.6) |
Among those developing NHL after AIDS | 152 | 2.0 (0.60-6.6) | 2.0 (0.55-7.0) |
KSHV antibodies: seroprevalent | 252 | 1.3 (0.68-2.5) | 0.85 (0.36-2.0) |